Rx HealthCare Services

rxnursing.com

Rx HealthCare Services understands that there is no place like home. We also know that there may come a time when you or a loved one is in need of additional nursing or a caregivers help in order to stay at home. That’s where we can lend a helping hand. We provide Home Health, Hospice, Behavioral Health, Care giving and Case Management. We have been providing care and services throughout the Sacramento Region since 1991.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MedTech

INSEMPRA ANNOUNCES STRATEGIC INVESTMENT IN SOLENA MATERIALS

Insempra, | July 26, 2022

news image

Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today announces a strategic investment in Solena Materials Ltd a synthetic biology company. Solena, a spin-out from Imperial College London, develops synthetic proteins for high-performance clothing fibers. The investment will allow Insempra, formerly Origin.Bio, to accelerate its strategy of harnessing new technologies to advance biological production processes, creating ...

Read More

Industrial Impact

AXION BIOSYSTEMS EXPANDS OPERATIONS WITH ACQUISITION OF M-SOLV MANUFACTURING LIMITED

Axion BioSystems | February 03, 2022

news image

Axion BioSystems, a leading life sciences tools company focused on advanced bioelectronic assay technologies, announces the acquisition of UK-based printed electronics manufacturer M-Solv Manufacturing Limited, a subsidiary of M-Solv Ltd. The creation of the new division, called Axion BioSystems Manufacturing, UK, Ltd., cements the six-year partnership between the companies and positions Axion for continued growth and innovation. “The need to control th...

Read More

Industrial Impact, Medical

PHARMING ANNOUNCES THE FIRST COMMERCIAL SHIPMENTS OF JOENJA® (LENIOLISIB) TO PATIENTS IN THE U.S.

Prnewswire | April 11, 2023

news image

Pharming Group N.V. announces the first commercial shipments of Joenja® to patients in the United States. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only treatment approved in the U.S. for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare and progressive primary immunodeficiency, in adult and pediatric patients 12 years of age and older. Under the terms of Pharming's 2019 exclusive license agreement with Novartis...

Read More

Cell and Gene Therapy

TAKEDA TO ACQUIRE ADAPTATE BIOTHERAPEUTICS TO DEVELOP NOVEL GAMMA DELTA (ΓΔ) T CELL ENGAGER THERAPIES TARGETING SOLID TUMORS

Takeda | January 11, 2022

news image

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire Adaptate Biotherapeutics a UK company focused on developing antibody-based therapeutics for the modulation of variable delta 1 (Vδ1) gamma delta (γδ) T cells. Through the acquisition, Takeda will obtain Adaptate’s antibody-based γδ T cell engager platform, including pre-clinical candidate and discovery pipeline programs. Adaptate’s γδ T cell engagers are des...

Read More
news image

MedTech

INSEMPRA ANNOUNCES STRATEGIC INVESTMENT IN SOLENA MATERIALS

Insempra, | July 26, 2022

Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today announces a strategic investment in Solena Materials Ltd a synthetic biology company. Solena, a spin-out from Imperial College London, develops synthetic proteins for high-performance clothing fibers. The investment will allow Insempra, formerly Origin.Bio, to accelerate its strategy of harnessing new technologies to advance biological production processes, creating ...

Read More
news image

Industrial Impact

AXION BIOSYSTEMS EXPANDS OPERATIONS WITH ACQUISITION OF M-SOLV MANUFACTURING LIMITED

Axion BioSystems | February 03, 2022

Axion BioSystems, a leading life sciences tools company focused on advanced bioelectronic assay technologies, announces the acquisition of UK-based printed electronics manufacturer M-Solv Manufacturing Limited, a subsidiary of M-Solv Ltd. The creation of the new division, called Axion BioSystems Manufacturing, UK, Ltd., cements the six-year partnership between the companies and positions Axion for continued growth and innovation. “The need to control th...

Read More
news image

Industrial Impact, Medical

PHARMING ANNOUNCES THE FIRST COMMERCIAL SHIPMENTS OF JOENJA® (LENIOLISIB) TO PATIENTS IN THE U.S.

Prnewswire | April 11, 2023

Pharming Group N.V. announces the first commercial shipments of Joenja® to patients in the United States. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only treatment approved in the U.S. for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare and progressive primary immunodeficiency, in adult and pediatric patients 12 years of age and older. Under the terms of Pharming's 2019 exclusive license agreement with Novartis...

Read More
news image

Cell and Gene Therapy

TAKEDA TO ACQUIRE ADAPTATE BIOTHERAPEUTICS TO DEVELOP NOVEL GAMMA DELTA (ΓΔ) T CELL ENGAGER THERAPIES TARGETING SOLID TUMORS

Takeda | January 11, 2022

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire Adaptate Biotherapeutics a UK company focused on developing antibody-based therapeutics for the modulation of variable delta 1 (Vδ1) gamma delta (γδ) T cells. Through the acquisition, Takeda will obtain Adaptate’s antibody-based γδ T cell engager platform, including pre-clinical candidate and discovery pipeline programs. Adaptate’s γδ T cell engagers are des...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us